DK0706796T3 - Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme - Google Patents

Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme

Info

Publication number
DK0706796T3
DK0706796T3 DK94914579T DK94914579T DK0706796T3 DK 0706796 T3 DK0706796 T3 DK 0706796T3 DK 94914579 T DK94914579 T DK 94914579T DK 94914579 T DK94914579 T DK 94914579T DK 0706796 T3 DK0706796 T3 DK 0706796T3
Authority
DK
Denmark
Prior art keywords
hydrogen
reincorporation
acyl
alkyl
parkinsonism
Prior art date
Application number
DK94914579T
Other languages
English (en)
Inventor
Takayuki Namiki
Toshihiro Morimoto
Kenichi Kishii
Nobuyuki Kawakatsu
Makoto Kimura
Kyoko Yamasaki
Mariko Onoda
Yuji Yoshiko
Kazunori Harada
Masayuki Yanagi
Takeshi Yamamoto
Masato Inazu
Masaki Mitani
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of DK0706796T3 publication Critical patent/DK0706796T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Eye Examination Apparatus (AREA)
  • Finger-Pressure Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94914579T 1993-06-25 1994-04-28 Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme DK0706796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15556493 1993-06-25
PCT/JP1994/000728 WO1995000149A1 (en) 1993-06-25 1994-04-28 Dopamine reincorporation inhibitor

Publications (1)

Publication Number Publication Date
DK0706796T3 true DK0706796T3 (da) 2001-03-26

Family

ID=15608814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94914579T DK0706796T3 (da) 1993-06-25 1994-04-28 Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme

Country Status (13)

Country Link
US (1) US5747493A (da)
EP (1) EP0706796B1 (da)
JP (1) JP3062249B2 (da)
KR (1) KR100307660B1 (da)
AT (1) ATE199318T1 (da)
AU (1) AU674955B2 (da)
CA (1) CA2163986A1 (da)
DE (1) DE69426771T2 (da)
DK (1) DK0706796T3 (da)
ES (1) ES2157258T3 (da)
GR (1) GR3035688T3 (da)
PT (1) PT706796E (da)
WO (1) WO1995000149A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
US4469695A (en) * 1980-02-25 1984-09-04 Ayerst, Mckenna & Harrison, Inc. 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
CS271571B1 (en) * 1987-12-10 1990-10-12 Protiva Miroslav Piperazine derivatives, their salts and method of their preparation
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
DE68903263T2 (de) * 1988-10-10 1993-05-19 Akzo Nv Substituierte aromatische verbindungen mit zentraler nervensystem-wirkung.
ATE107922T1 (de) * 1989-03-03 1994-07-15 Dainippon Pharmaceutical Co 2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
JPH0747574B2 (ja) * 1989-03-03 1995-05-24 大日本製薬株式会社 ピリジン誘導体及びそれを有効成分とする向精神剤
TW205034B (da) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
US5089497A (en) * 1990-09-20 1992-02-18 Warner-Lambert Company Substituted piperazines as central nervous system agents
CA2067475C (en) * 1991-05-08 2000-10-10 Yasuo Oshiro Carbostyril derivatives and their use

Also Published As

Publication number Publication date
WO1995000149A1 (en) 1995-01-05
KR960702310A (ko) 1996-04-27
PT706796E (pt) 2001-06-29
KR100307660B1 (ko) 2001-12-28
EP0706796A4 (en) 1999-03-24
JP3062249B2 (ja) 2000-07-10
AU6689194A (en) 1995-01-17
EP0706796B1 (en) 2001-02-28
GR3035688T3 (en) 2001-07-31
CA2163986A1 (en) 1995-01-05
DE69426771T2 (de) 2001-06-13
EP0706796A1 (en) 1996-04-17
ATE199318T1 (de) 2001-03-15
US5747493A (en) 1998-05-05
AU674955B2 (en) 1997-01-16
ES2157258T3 (es) 2001-08-16
DE69426771D1 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
CY1112800T1 (el) Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
NO911525D0 (no) Nye 2,9-disubstituerte-4h-pyrido(1,2-a)pyrimidin-4-oner.
ATE112764T1 (de) Diphenylpiperazinderivat.
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
BR9506552A (pt) Método de inibição de integrase retroviral
FR2672801B1 (fr) Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
FI935799A0 (fi) Arylsubstituerade heterocykliska foereningar
DK0706796T3 (da) Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
EP1325918A4 (en) INHIBITORS OF CARDIAC MUSCLE CELL APOPTOSIS AND THERAPEUTIC / PROPHYLACTIC AGENTS AGAINST HEART DISEASE
DE3884878D1 (de) Uricosuretische Zusammensetzung.
EP0653207A4 (en) AIDS VIRUS INFECTIVE COMPOSITION.
TH8168B (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด
UY26411A1 (es) Heterociclos biciclonitrogenados heteroalquil amino sustituidos